Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 497 articles:
HTML format



Single Articles


    April 2021
  1. MCLEESE RH, Spinou A, Alfahl Z, Tsagris M, et al
    Psychometrics of HRQoL questionnaires in bronchiectasis: A systematic review and meta-analysis.
    Eur Respir J. 2021 Apr 22. pii: 13993003.00025-2021.
    PubMed     Abstract available


  2. GAILLARD EA, Kuehni CE, Turner S, Goutaki M, et al
    European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.
    Eur Respir J. 2021 Apr 19. pii: 13993003.04173-2020.
    PubMed     Abstract available


  3. DURACK T, Chapman DG, Rutting S, Thamrin C, et al
    Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04400-2020.
    PubMed    


  4. MARCON A, Locatelli F, Dharmage SC, Svanes C, et al
    The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04656-2020.
    PubMed     Abstract available


  5. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    PubMed     Abstract available


  6. LUCCHETTI D, Santini G, Perelli L, Ricciardi-Tenore C, et al
    Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients.
    Eur Respir J. 2021 Apr 1. pii: 13993003.03024-2020.
    PubMed    


  7. TALAEI M, Hughes DA, Mahmoud O, Emmett PM, et al
    Dietary intake of vitamin A, lung function, and incident asthma in childhood.
    Eur Respir J. 2021 Apr 1. pii: 13993003.04407-2020.
    PubMed     Abstract available


    March 2021
  8. HIGBEE DH, Nava GW, Kwong ASF, Dodd JW, et al
    The impact of asthma on mental health & wellbeing during COVID-19 lockdown.
    Eur Respir J. 2021 Mar 25. pii: 13993003.04497-2020.
    PubMed    


  9. BRUSSELLE G, Nicolini G, Santoro L, Guastalla D, et al
    BDP/formoterol MART asthma exacerbation benefit increases with blood eosinophil level.
    Eur Respir J. 2021 Mar 18. pii: 13993003.040982020.
    PubMed    


  10. PRICE OJ, Kucera KL, Price HM, Drezner JA, et al
    Asthma-related sudden death in athletes: A retrospective analysis of the U.S. NCCSIR database (1982-2018).
    Eur Respir J. 2021 Mar 7. pii: 13993003.00088-2021.
    PubMed    


  11. WEE LE, Conceicao EP, Tan JY, Sim JXY, et al
    Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore.
    Eur Respir J. 2021 Mar 2. pii: 13993003.04493-2020.
    PubMed    


  12. KNIHTILA HM, Kelly RS, Brustad N, Huang M, et al
    Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze.
    Eur Respir J. 2021 Mar 2. pii: 13993003.02012-2020.
    PubMed     Abstract available


    February 2021
  13. MASOLI M, Lanario JW, Hyland ME, Menzies-Gow A, et al
    The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference (MCID).
    Eur Respir J. 2021 Feb 25. pii: 13993003.00300-2021.
    PubMed    


  14. REDDEL HK, Vestbo J, Agusti A, Anderson GP, et al
    Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.
    Eur Respir J. 2021 Feb 25. pii: 13993003.03927-2020.
    PubMed     Abstract available


  15. CHANG AB, Fortescue R, Grimwood K, Alexopoulou E, et al
    Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
    Eur Respir J. 2021 Feb 11. pii: 13993003.02990-2020.
    PubMed     Abstract available


  16. BUSSE WW, Kraft M, Rabe KF, Deniz Y, et al
    Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03393-2020.
    PubMed     Abstract available


  17. WANG R, Alahmadi F, Niven R, Fowler SJ, et al
    Same-day repeatability of fractional exhaled nitric oxide in severe asthma.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03391-2020.
    PubMed    


  18. REDDEL HK
    Reply: About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    PubMed    


  19. FERRETTI S, Gelsomino M, Miceli Sopo S
    About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    PubMed    


  20. PENN RB
    Honing in on the effectors of oxidative stress in the asthmatic lung: oxidised phosphatidylcholines.
    Eur Respir J. 2021;57.
    PubMed    


  21. BRUSASCO C, Corradi F, Di Domenico A, Raggi F, et al
    Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
    Eur Respir J. 2021;57.
    PubMed    


    January 2021
  22. ROGLIANI P, Ritondo BL, Calzetta L
    Triple therapy in uncontrolled asthma: a network meta-analysis of Phase III studies.
    Eur Respir J. 2021 Jan 28. pii: 13993003.04233-2020.
    PubMed     Abstract available


  23. GIAM YH, Shoemark A, Chalmers JD
    Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03157-2020.
    PubMed     Abstract available


  24. TALAEI M, Sdona E, Calder PC, Jones LR, et al
    Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype, and incident asthma.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03633-2020.
    PubMed     Abstract available


  25. BEAULIEU D, Attwe A, Breau M, Lipskaia L, et al
    Phospholipase A2-Receptor 1 Promotes Lung-Cell Senescence and Emphysema in Obstructive Lung Disease.
    Eur Respir J. 2021 Jan 28. pii: 13993003.00752-2020.
    PubMed     Abstract available


  26. RUFFLES T, Jones CJ, Palmer C, Turner S, et al
    Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents.
    Eur Respir J. 2021 Jan 21. pii: 13993003.04107-2020.
    PubMed     Abstract available


  27. MAGNAYE KM, Naughton KA, Huffman J, Hogarth DK, et al
    A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
    Eur Respir J. 2021 Jan 14. pii: 13993003.03862-2020.
    PubMed     Abstract available


  28. MURRAY CS, Lucas SJ, Blakey J, Kaplan A, et al
    A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care.
    Eur Respir J. 2021 Jan 8. pii: 13993003.03599-2020.
    PubMed     Abstract available


  29. SIBILA O
    Reducing Pseudomonas sputum density in bronchiectasis.
    Eur Respir J. 2021;57.
    PubMed    


  30. MOMEN NC, Liu X
    Maternal antibiotic use during pregnancy and asthma in children: population-based cohort study and sibling design.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    December 2020
  31. EGER K, Bel EH
    Asthma and COVID-19: do we finally have answers?
    Eur Respir J. 2020 Dec 30. pii: 13993003.04451-2020.
    PubMed    


  32. MOORE A, Preece A, Sharma R, Heaney LG, et al
    A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
    Eur Respir J. 2020 Dec 17. pii: 13993003.03103-2020.
    PubMed     Abstract available


  33. KRUG J, Kiefer A, Koelle J, Vuorinen T, et al
    TLR 7/8 regulates Type I and Type III Interferon Signalling in RV1b induced Allergic Asthma.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01562-2020.
    PubMed     Abstract available


  34. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2020 Dec 10. pii: 13993003.030992020.
    PubMed     Abstract available


  35. LONGO C, Blais L, Brownell M, Quail JM, et al
    Association between asthma control trajectories in preschoolers and disease remission.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01897-2020.
    PubMed     Abstract available


  36. HERNANDEZ-PACHECO N, Vijverberg SJ, Herrera-Luis E, Li J, et al
    Genome-wide association study of asthma exacerbations despite inhaled corticosteroids use.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03388-2020.
    PubMed     Abstract available


  37. O'BYRNE PM, Pavord ID
    A golden age of asthma research.
    Eur Respir J. 2020;56.
    PubMed    


  38. WALTERS EH, Shukla SD, Ward C
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    PubMed    


  39. HIGHAM A, Singh D
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    PubMed    


    November 2020
  40. CRICHTON ML, Dudgeon EK, Shoemark A, Chalmers JD, et al
    Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure.
    Eur Respir J. 2020 Nov 19. pii: 13993003.03156-2020.
    PubMed     Abstract available


  41. FARNE H, Singanayagam A
    Why asthma might surprisingly protect against poor outcomes in COVID-19.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03045-2020.
    PubMed    


  42. IZQUIERDO JL, Almonacid C, Gonzalez Y, Del Rio-Bermudez C, et al
    The Impact of COVID-19 on Patients with Asthma.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03142-2020.
    PubMed     Abstract available


  43. MERKUS PJ, Pijnenburg MW
    Diagnosing asthma in children or adolescents/young adults? It is time for a change! How timing is everything, also in clinical practice.
    Eur Respir J. 2020;56.
    PubMed    


  44. WHITMORE GA, Aaron SD
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    PubMed    


  45. PERRET JL, Vicendese D, Dharmage SC
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    PubMed    


  46. SAHANIC S, Boehm A, Pizzini A, Sonnweber T, et al
    Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends.
    Eur Respir J. 2020;56.
    PubMed    


    October 2020
  47. O'BYRNE PM, Reddel HK, Beasley R
    The Management of Mild Asthma.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03051-2020.
    PubMed     Abstract available


  48. YAN Q, Forno E, Herrera-Luis E, Pino-Yanes M, et al
    A genome-wide association study of severe asthma exacerbations in Latino children and adolescents.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02693-2020.
    PubMed     Abstract available


  49. HANON S, Brusselle G, Deschampheleire M, Louis R, et al
    COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02857-2020.
    PubMed    


  50. PAPI A, Braithwaite I, Ebmeier S, Hancox B, et al
    Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.
    Eur Respir J. 2020 Oct 15. pii: 13993003.03064-2020.
    PubMed    


  51. ILMARINEN P, Pardo A, Tuomisto LE, Vahatalo I, et al
    Long-term prognosis of new adult-onset asthma in obese patients.
    Eur Respir J. 2020 Oct 8. pii: 13993003.01209-2020.
    PubMed     Abstract available


  52. HOLZ O, Waschki B, Watz H, Kirsten A, et al
    Breath volatile organic compounds and inflammatory markers in adult asthma patients - negative results from the ALLIANCE cohort.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02127-2020.
    PubMed    


  53. KERMANI NZ, Pavlidis S, Xie J, Sun K, et al
    Instability of sputum molecular phenotypes in U-BIOPRED severe asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.01836-2020.
    PubMed    


  54. O'NEILL C, Gibson PG, Heaney LG, Upham JW, et al
    The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02436-2020.
    PubMed     Abstract available


  55. QUINN M, Turner AM
    Modernising case finding for alpha1-antitrypsin deficiency by DNA sequencing of COPD patients.
    Eur Respir J. 2020;56.
    PubMed    


  56. GLANVILLE AR
    Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction.
    Eur Respir J. 2020;56.
    PubMed    


  57. CAVIEDES I, Soto R, Herth F
    The determination of ventilatory inefficiency at rest in COPD: the expected parameter.
    Eur Respir J. 2020;56.
    PubMed    


    September 2020
  58. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19.
    Eur Respir J. 2020 Sep 25. pii: 13993003.02226-2020.
    PubMed     Abstract available


  59. ASHER MI, Garcia-Marcos L, Pearce NE, Strachan DP, et al
    "Trends in worldwide asthma prevalence".
    Eur Respir J. 2020 Sep 24. pii: 13993003.02094-2020.
    PubMed     Abstract available


  60. DAI X, Bui D, Perret JL, Lowe A, et al
    Exposure to household air pollution over 10 years is related to asthma and lung function decline.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00602-2020.
    PubMed     Abstract available


  61. THOMPSON CA, Eslick SR, Berthon BS, Wood LG, et al
    Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00612-2020.
    PubMed     Abstract available


  62. BURGESS JK, Jonker MR, Berg M, Ten Hacken NTH, et al
    Periostin: contributor to abnormal airway epithelial function in asthma?
    Eur Respir J. 2020 Sep 9. pii: 13993003.01286-2020.
    PubMed     Abstract available


  63. ALIBERTI S, Sotgiu G, Martinez Garcia MA
    Blood eosinophils do not predict inhaled budesonide response in bronchiectasis.
    Eur Respir J. 2020;56.
    PubMed    


  64. LIPWORTH B, Chan R, Kuo CR
    Systemic effects of fluticasone on blood eosinophils in bronchiectasis.
    Eur Respir J. 2020;56.
    PubMed    


  65. CALVERLEY PMA, Farre R
    Oscillometry: old physiology with a bright future.
    Eur Respir J. 2020;56.
    PubMed    


    August 2020
  66. LOEBINGER MR, Polverino E, Chalmers JD, Tiddens HAWM, et al
    Efficacy and safety of TOBI Podhaler(R) in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.
    Eur Respir J. 2020 Aug 27. pii: 13993003.01451-2020.
    PubMed     Abstract available


  67. LEE S, Lasky-Su JA, Lange C, Kim W, et al
    A Novel Locus for Exertional Dyspnea in Childhood Asthma.
    Eur Respir J. 2020 Aug 27. pii: 13993003.01224-2020.
    PubMed     Abstract available


  68. VEDEL-KROGH S, Rasmussen KL, Nordestgaard BG, Nielsen SF, et al
    Complement C3 and allergic asthma: A cohort study of the general population.
    Eur Respir J. 2020 Aug 18. pii: 13993003.00645-2020.
    PubMed     Abstract available


  69. HARRISON T, Canonica GW, Chupp G, Lee J, et al
    Real-world mepolizumab in the prospective severe asthma REALITI-A study - initial analysis.
    Eur Respir J. 2020 Aug 13. pii: 13993003.00151-2020.
    PubMed     Abstract available


  70. REIJULA J, Latvala J, Makela M, Siitonen S, et al
    Long-term trends of asthma, allergic rhinitis and atopic eczema in Finnish young men: a retrospective analysis, 19262017.
    Eur Respir J. 2020 Aug 6. pii: 13993003.02144-2019.
    PubMed     Abstract available


  71. CHALITSIOS CV, McKeever TM, Shaw DE
    Incidence of osteoporosis and fragility fractures in asthma: a UK population-based matched cohort study.
    Eur Respir J. 2020 Aug 6. pii: 13993003.01251-2020.
    PubMed     Abstract available


  72. WANG K, Verbakel JY, Oke J, Fleming-Nouri A, et al
    Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations.
    Eur Respir J. 2020;56.
    PubMed    


  73. PEREZ DE LLANO L, Blanco Cid N, Martin Robles I, Golpe R, et al
    Regarding the role of F ENO in predicting failure after ICS reduction in mild-to-moderate asthma patients.
    Eur Respir J. 2020;56.
    PubMed    


  74. LEUNG JM, Niikura M, Yang CWT, Sin DD, et al
    COVID-19 and COPD.
    Eur Respir J. 2020;56.
    PubMed    


  75. JACOBS M, Van Eeckhoutte HP, Wijnant SRA, Janssens W, et al
    Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects.
    Eur Respir J. 2020;56.
    PubMed    


  76. CONNELL D, Shah A
    The contribution of Aspergillus fumigatus to COPD exacerbations: a "sensitive" topic.
    Eur Respir J. 2020;56.
    PubMed    


  77. NANZER AM, D'Ancona G, Kelly PA, Jackson DJ, et al
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    PubMed    


  78. LIPWORTH B, Chan R, Kuo CR
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    PubMed    


    July 2020
  79. BEURNIER A, Jutant EM, Jevnikar M, Boucly A, et al
    Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation.
    Eur Respir J. 2020 Jul 30. pii: 13993003.01875-2020.
    PubMed     Abstract available


  80. FREITAS PD, Xavier RF, McDonald VM, Gibson PG, et al
    Identification of asthma phenotypes based on extrapulmonary treatable traits.
    Eur Respir J. 2020 Jul 30. pii: 13993003.00240-2020.
    PubMed     Abstract available


  81. KENDZERSKA T, Aaron SD, To T, Licskai C, et al
    The Effect of Type and Dosage of Newly Prescribed Inhaled Corticosteroids on Obstructive Lung Disease and Pneumonia Hospitalisations in Older Individuals with Asthma, Chronic Obstructive Pulmonary Disease (COPD) or Both: A Retrospective Study of Healt
    Eur Respir J. 2020 Jul 23. pii: 13993003.02585-2020.
    PubMed    


  82. PENN RB
    Mast cells in asthma: Here I am, stuck in the middle with you.
    Eur Respir J. 2020;56.
    PubMed    


  83. FARSALINOS K, Angelopoulou A, Alexandris N, Poulas K, et al
    COVID-19 and the nicotinic cholinergic system.
    Eur Respir J. 2020;56.
    PubMed    


  84. LEUNG JM, Sin DD
    Smoking, ACE-2 and COVID-19: ongoing controversies.
    Eur Respir J. 2020;56.
    PubMed    


  85. MCALINDEN KD, Eapen MS, Lu W, Chia C, et al
    COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
    Eur Respir J. 2020;56.
    PubMed    


  86. LUTCHMAN D
    Could the smoking gun in the fight against COVID-19 be the (rh)ACE-2?
    Eur Respir J. 2020;56.
    PubMed    


  87. VAN MEEL ER, Attanasi M, Jaddoe VWV, Reiss IKM, et al
    C hlamydia trachomatis during pregnancy and childhood asthma-related morbidity: a population-based prospective cohort.
    Eur Respir J. 2020;56.
    PubMed     Abstract available


  88. TO T, Viegi G, Cruz A, Taborda-Barata L, et al
    A global respiratory perspective on the COVID-19 pandemic: commentary and action proposals.
    Eur Respir J. 2020;56.
    PubMed    


  89. JOHNSON MJ, Ekstrom M, Currow DC
    Observational studies and "the eye of the beholder".
    Eur Respir J. 2020;56.
    PubMed    


  90. KUGELMAN A
    High-flow nasal cannula therapy: can it be recommended as initial or rescue care for infants with moderate bronchiolitis in the paediatric ward?
    Eur Respir J. 2020;56.
    PubMed    


  91. CHALMERS JD, Miravitlles M
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    PubMed    


  92. AGUSTI A
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    PubMed    


  93. TRINKMANN F, Watz H, Herth FJF
    Why do we still cling to spirometry for assessing small airway function?
    Eur Respir J. 2020;56.
    PubMed    


  94. BOURDIN A, Gamez AS, Vachier I, Crestani B, et al
    LAM is another small airway disease: lessons from microCT.
    Eur Respir J. 2020;56.
    PubMed    


  95. ARSHAD SH, Kurukulaaratchy R, Zhang H, Hodgekiss C, et al
    Assessing small airway function for early detection of lung function impairment.
    Eur Respir J. 2020;56.
    PubMed    


    June 2020
  96. PORSBJERG CM, Sverrild A, Lloyd CM, Menzies-Gow AN, et al
    Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics.
    Eur Respir J. 2020 Jun 25. pii: 13993003.00260-2020.
    PubMed     Abstract available


  97. HINKS TS, Levine SJ, Brusselle GG
    Treatment options in type-2 low asthma.
    Eur Respir J. 2020 Jun 25. pii: 13993003.00528-2020.
    PubMed     Abstract available


  98. DURRINGTON HJ, Krakowiak K, Meijer P, Begley N, et al
    Circadian asthma airway responses are gated by REV-ERBalpha.
    Eur Respir J. 2020 Jun 25. pii: 13993003.02407-2019.
    PubMed     Abstract available


  99. GRAMEGNA A, Aliberti S, Sibila O, Di Francesco C, et al
    Sputum neutrophil elastase in bronchiectasis: a Southern European cohort study.
    Eur Respir J. 2020 Jun 25. pii: 13993003.01702-2020.
    PubMed    


  100. CHALMERS JD, Cipolla D, Thompson B, Davis AM, et al
    Changes in respiratory symptoms during 48 weeks treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies.
    Eur Respir J. 2020 Jun 18. pii: 13993003.00110-2020.
    PubMed     Abstract available


  101. MURRAY LM, Yerkovich ST, Ferreira MA, Upham JW, et al
    Risks for cold frequency vary by sex: role of asthma, age, TLR7 and leukocyte subsets.
    Eur Respir J. 2020 Jun 8. pii: 13993003.02453-2019.
    PubMed     Abstract available


  102. BLOMME EE, Provoost S, Bazzan E, Van Eeckhoutte HP, et al
    Innate lymphoid cells in isocyanate-induced asthma: role of microRNA-155.
    Eur Respir J. 2020 Jun 4. pii: 13993003.01289-2019.
    PubMed     Abstract available


  103. DE JONG CC, Pedersen ES, Mozun R, Muller-Suter D, et al
    Diagnosis of asthma in children: findings from the Swiss Paediatric Airway Cohort.
    Eur Respir J. 2020 Jun 4. pii: 13993003.00132-2020.
    PubMed     Abstract available


  104. ORIANO M, Gramegna A, Terranova L, Sotgiu G, et al
    Sputum Neutrophil Elastase associates with microbiota and P. aeruginosa in bronchiectasis.
    Eur Respir J. 2020 Jun 4. pii: 13993003.00769-2020.
    PubMed     Abstract available


  105. BARBIELLINI AMIDEI C, Comoretto R, Zanier L, Dona D, et al
    Acid-suppressive medications in the first year of life and risk of childhood asthma: a population-based birth cohort study.
    Eur Respir J. 2020 Jun 4. pii: 13993003.00197-2020.
    PubMed    


  106. LEUNG JM, Yang CX, Sin DD
    Reply to: "Current smoking is not associated with COVID-19".
    Eur Respir J. 2020;55.
    PubMed    


  107. ROSSATO M, Russo L, Mazzocut S, Di Vincenzo A, et al
    Current smoking is not associated with COVID-19.
    Eur Respir J. 2020;55.
    PubMed    


  108. LEUNG JM, Yang CX, Sin DD
    COVID-19 and nicotine as a mediator of ACE-2.
    Eur Respir J. 2020;55.
    PubMed    


  109. RUSSO P, Bonassi S, Giacconi R, Malavolta M, et al
    COVID-19 and smoking: is nicotine the hidden link?
    Eur Respir J. 2020;55.
    PubMed    


  110. RUSSELL REK, Wang K
    Finding the true prevalence of obstructive lung disease: two steps forward and one step back.
    Eur Respir J. 2020;55.
    PubMed    


  111. ROCHE N, Tonia T, Miravitlles M, Vaccaro V, et al
    Expanding the spectrum of European Respiratory Society official scientific documents: short documents complement clinical practice guidelines, statements and technical standards.
    Eur Respir J. 2020;55.
    PubMed    


    May 2020
  112. WADA T, Jaw JE, Tsuruta M, Moritani K, et al
    External Radiofrequency as a Novel Extracorporeal Therapy for Emphysema.
    Eur Respir J. 2020 May 29. pii: 13993003.01422-2020.
    PubMed    


  113. MUKHERJEE M, Forero DF, Tran S, Boulay ME, et al
    Sub-optimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena.
    Eur Respir J. 2020 May 22. pii: 13993003.00117-2020.
    PubMed     Abstract available


  114. BAGGOTT C, Hardy J, Sparks J, Holliday M, et al
    Self-titration of inhaled corticosteroid and beta2-agonist in response to symptoms in mild asthma - a pre-specified analysis from the PRACTICAL study, a randomised controlled trial.
    Eur Respir J. 2020 May 22. pii: 13993003.00170-2020.
    PubMed     Abstract available


  115. ROGLIANI P, Ritondo BL, Ora J, Cazzola M, et al
    SMART and as-needed therapies in mild to severe asthma: a network meta-analysis.
    Eur Respir J. 2020 May 19. pii: 13993003.00625-2020.
    PubMed     Abstract available


  116. TAYTARD J, Aupiais C, Jovien S, Assouline Kabla J, et al
    Effect of Long-Acting Beta-Agonist on bronchodilator response in asthmatic children.
    Eur Respir J. 2020 May 19. pii: 13993003.02010-2019.
    PubMed    


  117. SINGH D, Virchow JC, Canonica GW, Vele A, et al
    Extrafine triple therapy in patients with asthma and persistent airflow limitation.
    Eur Respir J. 2020 May 19. pii: 13993003.00476-2020.
    PubMed    


  118. ALIBERTI S, Sotgiu G, Blasi F, Saderi L, et al
    Blood eosinophils predict inhaled fluticasone response in bronchiectasis.
    Eur Respir J. 2020 May 12. pii: 13993003.00453-2020.
    PubMed    


  119. EXARCHOS KP, Beltsiou M, Votti CA, Kostikas K, et al
    Artificial Intelligence techniques in Asthma:A systematic review and critical appraisal of the existing literature.
    Eur Respir J. 2020 May 7. pii: 13993003.00521-2020.
    PubMed     Abstract available


  120. HOANG TT, Sikdar S, Xu CJ, Lee MK, et al
    Epigenome-Wide Association Study of DNA Methylation and Adult Asthma in the Agricultural Lung Health Study.
    Eur Respir J. 2020 May 7. pii: 13993003.00217-2020.
    PubMed     Abstract available


  121. TAYLOR SL, Ivey KL, Gibson PG, Simpson JL, et al
    Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma.
    Eur Respir J. 2020 May 4. pii: 13993003.00194-2020.
    PubMed    


  122. COSTELLO RW, Cushen B
    Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma.
    Eur Respir J. 2020;55.
    PubMed    


  123. LEUNG JM, Yang CX, Tam A, Shaipanich T, et al
    ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.
    Eur Respir J. 2020;55.
    PubMed    


  124. DINH-XUAN AT, Brusselle G
    F ENO as a biomarker guide for inhaled corticosteroid step down in patients with mild-to-moderate well-controlled asthma.
    Eur Respir J. 2020;55.
    PubMed    


  125. STOLZ D, Miravitlles M
    The right treatment for the right patient with COPD: lessons from the IMPACT trial.
    Eur Respir J. 2020;55.
    PubMed    


  126. VEDEL-KROGH S
    The search for the "healthy" blood eosinophil count.
    Eur Respir J. 2020;55.
    PubMed    


  127. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    A clinically significant bronchodilator response in children: how should it be measured?
    Eur Respir J. 2020;55.
    PubMed    


  128. GUEZGUEZ F, Ben Saad H
    What constitutes a "clinically significant" bronchodilator response in children?
    Eur Respir J. 2020;55.
    PubMed    


  129. HALPIN DMG, Dransfield MT, Han MK, Jones CE, et al
    The effect of exacerbation history on outcomes in the IMPACT trial.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  130. SCHEERENS C, Faes K, Pype P, Beernaert K, et al
    Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  131. MATHIOUDAKIS AG, Bikov A, Foden P, Lahousse L, et al
    Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  132. HARTL S, Breyer MK, Burghuber OC, Ofenheimer A, et al
    Blood eosinophil count in the general population: typical values and potential confounders.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  133. JOGDAND P, Siddhuraj P, Mori M, Sanden C, et al
    Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  134. THULBORN SJ, Cane JL, Connolly C, Borg C, et al
    Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD.
    Eur Respir J. 2020;55.
    PubMed    


  135. LEONG P, Ruane LE, Phyland D, Koh J, et al
    Inspiratory vocal cord closure in COPD.
    Eur Respir J. 2020;55.
    PubMed    


    April 2020
  136. HANSEN ESH, Pitzner-Fabricius A, Toennesen LL, Rasmusen HK, et al
    Effect of aerobic exercise training on asthma in adults - A systematic review and meta-analysis.
    Eur Respir J. 2020 Apr 29. pii: 13993003.00146-2020.
    PubMed     Abstract available


  137. TOPPILA-SALMI S, Luukkainen AT, Xu B, Lampi J, et al
    Maternal smoking during pregnancy affects adult onset of asthma in offspring: a follow up from birth to age 46 years.
    Eur Respir J. 2020 Apr 27. pii: 13993003.01857-2019.
    PubMed     Abstract available


  138. PRETEROTI M, Whitmore GA, Vandemheen KL, Mark FitzGerald J, et al
    Population-Based Case-Finding to Identify Subjects with Undiagnosed Asthma or COPD.
    Eur Respir J. 2020 Apr 16. pii: 13993003.00024-2020.
    PubMed     Abstract available


  139. IJPMA G, Kachmar L, Panariti A, Matusovsky OS, et al
    Intrapulmonary airway smooth muscle is hyperreactive with a distinct proteome in asthma.
    Eur Respir J. 2020 Apr 16. pii: 13993003.02178-2019.
    PubMed     Abstract available


  140. GEHRING U, Wijga AH, Koppelman GH, Vonk JM, et al
    Air pollution and the development of asthma from birth until young adulthood.
    Eur Respir J. 2020 Apr 16. pii: 13993003.00147-2020.
    PubMed     Abstract available


  141. BONVINI SJ, Birrell MA, Dubuis E, Adcock JJ, et al
    Novel airway smooth muscle-mast cell interactions and a role for the TRPV4-ATP axis in non-atopic asthma.
    Eur Respir J. 2020 Apr 16. pii: 13993003.01458-2019.
    PubMed     Abstract available


  142. TURK Y, Theel W, van Huisstede A, van de Geijn GM, et al
    Short-term and long-term effect of a high intensity pulmonary rehabilitation program in obese patients with asthma: a randomised controlled trial.
    Eur Respir J. 2020 Apr 16. pii: 13993003.01820-2019.
    PubMed     Abstract available


  143. NEALE J, Orme MW, Majd S, Chantrell S, et al
    A comparison of daily physical activity profiles between adults with severe asthma and healthy controls.
    Eur Respir J. 2020 Apr 7. pii: 13993003.02219-2019.
    PubMed    


  144. CRICHTON ML, Lonergan M, Barker AF, Sibila O, et al
    Inhaled Aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post-hoc analysis of the AIR-BX studies.
    Eur Respir J. 2020 Apr 7. pii: 13993003.00608-2020.
    PubMed     Abstract available


  145. TAILLE C, Chanez P, Devouassoux G, Didier A, et al
    Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme.
    Eur Respir J. 2020 Apr 2. pii: 13993003.02345-2019.
    PubMed     Abstract available


  146. CHARRIOT J, Gaga M, Suehs C, Bourdin A, et al
    Asthma rescue treatments, time to reboot.
    Eur Respir J. 2020;55.
    PubMed    


  147. CELLI B, Fabbri LM
    Urgent need of a management plan for survivors of COVID-19.
    Eur Respir J. 2020;55.
    PubMed    


  148. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    Achieving the balance between evidence and simplicity.
    Eur Respir J. 2020;55.
    PubMed    


  149. LIPWORTH B, Kuo CR, Chan R
    Making simple things complicated using anti-inflammatory reliever therapy.
    Eur Respir J. 2020;55.
    PubMed    


  150. DIVO MJ
    The adipose tissue and lung health: like many things in life, the extremes are not good.
    Eur Respir J. 2020;55.
    PubMed    


    March 2020
  151. NANZER A, Chowdhury A, Raheem A, Roxas C, et al
    Prevalence and Recovery of Adrenal Insufficiency in Steroid-Dependent Asthma Patients Receiving Biologic Therapy.
    Eur Respir J. 2020 Mar 26. pii: 13993003.02273-2019.
    PubMed    


  152. VROMAN H, Tindemans I, Lukkes M, van Nimwegen M, et al
    Type II conventional DCs of asthmatic patients with frequent exacerbations have an altered phenotype and frequency.
    Eur Respir J. 2020 Mar 26. pii: 13993003.00859-2019.
    PubMed    


  153. ALCARAZ-SERRANO V, Gimeno-Santos E, Scioscia G, Gabarrus A, et al
    Association between physical activity and risk of hospitalisation in bronchiectasis.
    Eur Respir J. 2020 Mar 17. pii: 13993003.02138-2019.
    PubMed     Abstract available


  154. ALI MK, Kim RY, Brown AC, Mayall JR, et al
    Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma.
    Eur Respir J. 2020 Mar 17. pii: 13993003.01340-2019.
    PubMed     Abstract available


  155. HANCOX RJ, Morgan J, Dickson N, Connor J, et al
    Rape, asthma, and dysfunctional breathing.
    Eur Respir J. 2020 Mar 17. pii: 13993003.02455-2019.
    PubMed    


  156. FIELDING SS, Pijnenburg M, de Jongste J, Pike K, et al
    Does treatment guided by fractional exhaled nitric oxide improve outcomes in subgroups of children with asthma?
    Eur Respir J. 2020 Mar 12. pii: 13993003.01879-2019.
    PubMed     Abstract available


  157. TRAN TN, King E, Sarkar R, Nan C, et al
    Oral Corticosteroid Prescription Patterns for Asthma in France, Germany, Italy, and the United Kingdom.
    Eur Respir J. 2020 Mar 12. pii: 13993003.02363-2019.
    PubMed     Abstract available


  158. GEALE K, Darabi H, Lindh M, Wahl HF, et al
    NORDSTAR - Paving the way for a new era in asthma research.
    Eur Respir J. 2020 Mar 12. pii: 13993003.02476-2019.
    PubMed    


  159. SHAHEEN SO, Gissler M, Devereux G, Erkkola M, et al
    Maternal iron supplementation in pregnancy and asthma in the offspring: follow-up of a randomised trial in Finland.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02335-2019.
    PubMed    


  160. WANG K, Verbakel JY, Oke J, Fleming-Nouri A, et al
    Using fractional exhaled nitric oxide to guide step down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02150-2019.
    PubMed     Abstract available


  161. SLOB EMA, Brew BK, Vijverberg SJH, Kats CJAR, et al
    Early-life antibiotic use and risk of asthma and eczema: results of a discordant twin study.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02021-2019.
    PubMed     Abstract available


  162. HARVEY ES, Langton D, Katelaris C, Stevens S, et al
    Mepolizumab effectiveness and identification of super-responders in severe asthma.
    Eur Respir J. 2020 Mar 5. pii: 13993003.02420-2019.
    PubMed     Abstract available


  163. LIPWORTH B, Kuo CR, Chan R
    Systemic potency of fluticasone in asthma.
    Eur Respir J. 2020;55.
    PubMed    


  164. BUSSE WW
    Treatable traits: a step closer to the "holy grail" of asthma control?
    Eur Respir J. 2020;55.
    PubMed    


  165. SUISSA S, Ernst P
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


  166. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


  167. COLAK Y, Nordestgaard BG, Vestbo J, Lange P, et al
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    PubMed    


  168. RENNARD SI
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    PubMed    


  169. POLVERINO F, Soriano JB
    Small airways and early origins of COPD: pathobiological and epidemiological considerations.
    Eur Respir J. 2020;55.
    PubMed    


    February 2020
  170. DEVULDER J, Chenivesse C, Ledroit V, Fry S, et al
    Aberrant anti-viral response of Natural Killer cell in severe asthma.
    Eur Respir J. 2020 Feb 27. pii: 13993003.02422-2018.
    PubMed     Abstract available


  171. D'ANCONA G, Kavanagh J, Roxas C, Green L, et al
    Adherence to Inhaled Corticosteroids and Clinical Outcomes in Mepolizumab Therapy for Severe Asthma.
    Eur Respir J. 2020 Feb 20. pii: 13993003.02259-2019.
    PubMed     Abstract available


  172. BAGGOTT C, Reddel HK, Hardy J, Sparks J, et al
    Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma - findings from the PRACTICAL study, a randomised clinical trial.
    Eur Respir J. 2020 Feb 6. pii: 13993003.02073-2019.
    PubMed     Abstract available


  173. REDDEL HK
    GINA recommendations in adults with symptomatic mild asthma and a smoking history.
    Eur Respir J. 2020;55.
    PubMed    


  174. THOMSON NC, Chaudhuri R
    GINA recommendations in adults with symptomatic mild asthma and a smoking history.
    Eur Respir J. 2020;55.
    PubMed    


  175. SCHLEICH FN, Zanella D, Focant JF
    Exhaled volatile organic compounds for better asthma control: could it be a future noninvasive adherence test?
    Eur Respir J. 2020;55.
    PubMed    


  176. NILSSON U, Vanfleteren LEGW
    Troponin as a biomarker for mortality in stable COPD.
    Eur Respir J. 2020;55.
    PubMed    


  177. ERGAN B, Scala R, Windisch W
    Defining "stable chronic hypercapnia" in patients with COPD: the physiological perspective.
    Eur Respir J. 2020;55.
    PubMed    


  178. HEDSUND C, Wilcke TR, Berg RMG
    Defining "stable chronic hypercapnia" in patients with COPD: the physiological perspective.
    Eur Respir J. 2020;55.
    PubMed    


    January 2020
  179. BACHERT C, Humbert M, Hanania NA, Zhang N, et al
    Staphylococcus aureus and its IgE-inducing Enterotoxins in Asthma: Current Knowledge.
    Eur Respir J. 2020 Jan 24. pii: 13993003.01592-2019.
    PubMed     Abstract available


  180. COTTIN V, Nasser M, Traclet J, Chalabreysse L, et al
    Prolidase deficiency: a new genetic cause of combined pulmonary fibrosis and emphysema syndrome in the adult.
    Eur Respir J. 2020 Jan 24. pii: 13993003.01952-2019.
    PubMed    


  181. HULS A, Vanker A, Gray D, Koen N, et al
    Genetic susceptibility to asthma increases the vulnerability to indoor air pollution.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01831-2019.
    PubMed     Abstract available


  182. MENZIES-GOW A, Mansur AH, Brightling CE
    Clinical utility of fractional exhaled nitric oxide (FeNO) in severe asthma management.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01633-2019.
    PubMed     Abstract available


  183. NWARU BI, Ekstrom M, Hasvold P, Wiklund F, et al
    Overuse of short-acting beta2-agonists in asthma is associated with increased risk of exacerbation and mortality: A nationwide cohort study of the global SABINA programme.
    Eur Respir J. 2020 Jan 16. pii: 13993003.01872-2019.
    PubMed     Abstract available


  184. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.
    Eur Respir J. 2020;55.
    PubMed    


  185. BURGEL PR
    Airway mucus accumulation in COPD: the cholinergic paradox!
    Eur Respir J. 2020;55.
    PubMed    


  186. LENFERINK A, van der Palen J, van der Valk PDLPM, Burt MG, et al
    It is time to further expand research in tailoring self-management of COPD exacerbations!
    Eur Respir J. 2020;55.
    PubMed    


  187. RAMAKRISHNAN S, Bafadhel M
    Is it time to give up on "self-management" of COPD exacerbations?
    Eur Respir J. 2020;55.
    PubMed    


  188. COLAK Y, Afzal S
    Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry.
    Eur Respir J. 2020;55.
    PubMed    


  189. ADIBI A, Sadatsafavi M
    Looking at the COPD spectrum through "PRISm".
    Eur Respir J. 2020;55.
    PubMed    


  190. BOURDIN A, Suehs C, Charriot J
    Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship.
    Eur Respir J. 2020;55.
    PubMed    


  191. HAMAD G, Rigby A, Morice AH
    Prognostic significance of chronic respiratory symptoms in individuals with normal spirometry.
    Eur Respir J. 2020;55.
    PubMed    


    December 2019
  192. KIM S, Forno E, Yan Q, Jiang Y, et al
    SNPs identified by GWAS affect asthma risk through DNA methylation and expression of cis-genes in airway epithelium.
    Eur Respir J. 2019 Dec 12. pii: 13993003.02079-2019.
    PubMed     Abstract available


  193. ARSHAD SH, Hodgekiss C, Holloway JW, Kurukulaaratchy R, et al
    Association of asthma and smoking with lung function impairment in adolescence and early adulthood; the Isle of Wight Birth Cohort Study.
    Eur Respir J. 2019 Dec 12. pii: 13993003.00477-2019.
    PubMed     Abstract available


  194. MCDONALD VM, Clark VL, Cordova-Rivera L, Wark PAB, et al
    Targeting Treatable Traits in Severe Asthma: A Randomised Controlled Trial.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01509-2019.
    PubMed     Abstract available


  195. SERAJEDDINI H, Eddy RL, Licskai C, McCormack DG, et al
    FEV1 and MRI Ventilation Defect Reversibility in Asthma and COPD.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01947-2019.
    PubMed    


  196. CABRERA CS, Nan C, Lindarck N, Beekman MJHI, et al
    SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting beta2-agonist use in asthma.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01858-2019.
    PubMed     Abstract available


  197. FOY B, Kay D, Siddiqui S, Brightling C, et al
    Increased ventilation heterogeneity in asthma can be attributed to proximal bronchioles.
    Eur Respir J. 2019 Dec 5. pii: 13993003.01345-2019.
    PubMed    


  198. TO T, Zhu J, Stieb D, Gray N, et al
    Early Life Exposure to Air Pollution and Incidence of Childhood Asthma, Allergic Rhinitis and Eczema.
    Eur Respir J. 2019 Dec 5. pii: 13993003.00913-2019.
    PubMed     Abstract available


  199. BOUSQUET J, Anto JM, Bachert C, Bosnic-Anticevich S, et al
    From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity.
    Eur Respir J. 2019;54.
    PubMed    


    November 2019
  200. ABDULLAH K, Zhu J, Gershon A, Dell S, et al
    Effect of asthma exacerbation during pregnancy in women with asthma: A population-based cohort study.
    Eur Respir J. 2019 Nov 26. pii: 13993003.01335-2019.
    PubMed     Abstract available


  201. KIM YM, Kim H, Lee S, Kim S, et al
    Airway G-CSF identifies neutrophilic inflammation and contributes to asthma progression.
    Eur Respir J. 2019 Nov 19. pii: 13993003.00827-2019.
    PubMed     Abstract available


  202. WANG L, Chitano P, Pare PD, Seow CY, et al
    Upregulation of smooth muscle Rho-kinase protein expression in human asthma.
    Eur Respir J. 2019 Nov 14. pii: 13993003.01785-2019.
    PubMed    


  203. OSEI ET, Brandsma CA, Timens W, Heijink IH, et al
    Current perspectives on the role of Interleukin-1 signaling in the pathogenesis of Asthma and COPD.
    Eur Respir J. 2019 Nov 14. pii: 13993003.00563-2019.
    PubMed     Abstract available


  204. VERMEULEN CJ, Xu CJ, Vonk JM, Ten Hacken NHT, et al
    Differential DNA methylation in bronchial biopsies between persistent asthma and asthma in remission.
    Eur Respir J. 2019 Nov 14. pii: 13993003.01280-2019.
    PubMed     Abstract available


  205. GIBSON PG, Foster PS
    Neutrophilic asthma: welcome back!
    Eur Respir J. 2019;54.
    PubMed    


  206. REDDEL HK
    Response: The most fundamental change in asthma management in 30 years?
    Eur Respir J. 2019;54.
    PubMed    


  207. AMIRAV I, Newhouse MT
    The most fundamental change in asthma management in 30 years?
    Eur Respir J. 2019;54.
    PubMed    


  208. GAGA M, Zervas E
    Oral steroids in asthma: a double-edged sword.
    Eur Respir J. 2019;54.
    PubMed    



  209. ERJ November Podcast: Macrolides in severe asthma.
    Eur Respir J. 2019;54.
    PubMed    


    October 2019
  210. COSTA CM, Neder JA, Verrastro CG, Paula-Ribeiro M, et al
    Uncovering the mechanisms of exertional dyspnoea in combined pulmonary fibrosis and emphysema.
    Eur Respir J. 2019 Oct 24. pii: 13993003.01319-2019.
    PubMed     Abstract available


  211. RADEMACHER J, Konwert S, Fuge J, Dettmer S, et al
    Anti-IL5 and anti-IL5Ralpha therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01333-2019.
    PubMed    


  212. KATAYAMA S, Hammar KS, Krjutskov K, Einarsdottir E, et al
    Acute wheeze-specific gene module shows correlation with vitamin D and asthma medication.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01330-2019.
    PubMed     Abstract available


  213. ZHU Z, Zhu X, Liu CL, Shi H, et al
    Shared Genetics of Asthma and Mental Health Disorders: A Large-Scale Genome-Wide Cross-Trait Analysis.
    Eur Respir J. 2019 Oct 16. pii: 13993003.01507-2019.
    PubMed     Abstract available


  214. FITZGERALD JM, Buhl R, Casale TB, Jugovic B, et al
    Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma.
    Eur Respir J. 2019 Oct 16. pii: 13993003.00964-2019.
    PubMed    


  215. TANG HHF, Sly PD, Holt PG, Holt KE, et al
    Systems biology and big data in asthma and allergy - recent discoveries and emerging challenges.
    Eur Respir J. 2019 Oct 16. pii: 13993003.00844-2019.
    PubMed     Abstract available


  216. DIMA AL, van Ganse E, Stadler G, de Bruin M, et al
    Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study.
    Eur Respir J. 2019 Oct 10. pii: 13993003.00901-2019.
    PubMed     Abstract available


  217. VAN BRAGT JJMH, Adcock IM, Bel EHD, Braunstahl GJ, et al
    Characteristics and treatment regimens across ERS SHARP severe asthma registries.
    Eur Respir J. 2019 Oct 10. pii: 13993003.01163-2019.
    PubMed     Abstract available


  218. PEROTIN JM, Djukanovic R, Davies DE
    Regarding epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019;54.
    PubMed    


  219. HIEMSTRA PS, Sterk PJ
    Translation of in vitro findings to patients with asthma: a timely and compelling challenge.
    Eur Respir J. 2019;54.
    PubMed    


  220. WARD C, Kharaba ZJ
    Regarding epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019;54.
    PubMed    


  221. ANNESI-MAESANO I, Forastiere F
    Doubts about the adverse effects of air pollution on asthma?
    Eur Respir J. 2019;54.
    PubMed    


  222. WARK PAB
    Why are people with asthma more susceptible to influenza?
    Eur Respir J. 2019;54.
    PubMed    


    September 2019
  223. HOLGUIN F, Cardet JC, Chung KF, Diver S, et al
    Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline.
    Eur Respir J. 2019 Sep 26. pii: 13993003.00588-2019.
    PubMed     Abstract available


  224. MAIJERS I, Kearns N, Harper J, Weatherall M, et al
    Oral steroid sparing effect of high dose inhaled corticosteroids in asthma.
    Eur Respir J. 2019 Sep 26. pii: 13993003.01147-2019.
    PubMed     Abstract available


  225. SPIRO SG, Shah PL, Rintoul RC, George J, et al
    Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00581-2019.
    PubMed     Abstract available


  226. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    Diagnosis of asthma in children: the contribution of a detailed history and test results.
    Eur Respir J. 2019 Sep 12. pii: 13993003.01326-2019.
    PubMed     Abstract available


  227. HILES SA, McDonald VM, Guilhermino M, Brusselle GG, et al
    Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis.
    Eur Respir J. 2019 Sep 12. pii: 13993003.01381-2019.
    PubMed     Abstract available


  228. LEE H, Ryu J, Nam E, Chung SJ, et al
    Increased Mortality in Patients with Corticosteroid-dependent Asthma: A Nationwide Population-based Study.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00804-2019.
    PubMed     Abstract available


  229. BRINKMAN P, Ahmed WM, Gomez C, Knobel HH, et al
    Exhaled Volatile Organic Compounds as Markers for Medication Use in Asthma.
    Eur Respir J. 2019 Sep 12. pii: 13993003.00544-2019.
    PubMed     Abstract available


  230. ARDURA-GARCIA C, Arias E, Hurtado P, Bonnett LJ, et al
    Predictors of severe asthma attack re-attendance in Ecuadorian children: a cohort study.
    Eur Respir J. 2019 Sep 12. pii: 13993003.02419-2018.
    PubMed     Abstract available


  231. LJUNGBERG H, Carleborg A, Gerber H, Ofverstrom C, et al
    Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial.
    Eur Respir J. 2019 Sep 3. pii: 13993003.00983-2019.
    PubMed     Abstract available


  232. PUHAN MA
    Chronic respiratory symptoms but normal lung function: substantial disease burden but little evidence to inform practice.
    Eur Respir J. 2019;54.
    PubMed    


  233. SOLTANI A, Mahmood MQ, Reid DW, Walters EH, et al
    Cancer-protective effects of inhaled corticosteroids in COPD are likely related to modification of epithelial activation.
    Eur Respir J. 2019;54.
    PubMed    


  234. SUISSA S
    Inhaled corticosteroids and pneumonia mortality in COPD patients.
    Eur Respir J. 2019;54.
    PubMed    


  235. SUISSA S, Ariel A
    Misinterpretation of time-to-first event curves can lead to inappropriate treatment.
    Eur Respir J. 2019;54.
    PubMed    


  236. ALMAGRO P, Martinez-Camblor P, Soriano JB
    Inhaled corticosteroids and pneumonia mortality in COPD patients.
    Eur Respir J. 2019;54.
    PubMed    


  237. HARTLEY B, Criner GJ, Dransfield MT, Halpin DMG, et al
    Misinterpretation of time-to-first event curves can lead to inappropriate treatment.
    Eur Respir J. 2019;54.
    PubMed    


  238. FOWLER SJ, Sterk PJ
    Breath biomarkers in asthma: we're getting answers, but what are the important questions?
    Eur Respir J. 2019;54.
    PubMed    


  239. SPINOU A, Chalmers JD
    Respiratory physiotherapy in the bronchiectasis guidelines: is there a loud voice we are yet to hear?
    Eur Respir J. 2019;54.
    PubMed    


  240. ROCHE N, Anzueto A, Bosnic Anticevich S, Kaplan A, et al
    The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization.
    Eur Respir J. 2019;54.
    PubMed    


    August 2019
  241. BOURDIN A, Bjermer L, Brightling C, Brusselle G, et al
    ERS/EAACI Statement on severe exacerbations in asthma in adult: facts, priorities and key research questions.
    Eur Respir J. 2019 Aug 29. pii: 13993003.00900-2019.
    PubMed     Abstract available


  242. EVERAERTS S, McDonough JE, Verleden SE, Josipovic I, et al
    Airway morphometry in COPD with bronchiectasis: a view on all airway generations.
    Eur Respir J. 2019 Aug 29. pii: 13993003.02166-2018.
    PubMed     Abstract available


  243. RINGSHAUSEN FC, Rademacher J, Pink I, de Roux A, et al
    Increasing bronchiectasis prevalence in Germany, 2009-2017: a population-based cohort study.
    Eur Respir J. 2019 Aug 29. pii: 13993003.00499-2019.
    PubMed    


  244. BULLONE M, Carriero V, Bertolini F, Folino A, et al
    Elevated serum IgE, OCS-dependence and IL-17/22 expression in highly neutrophilic asthma.
    Eur Respir J. 2019 Aug 22. pii: 13993003.00068-2019.
    PubMed     Abstract available


  245. KELLY RS, Chawes BL, Guo F, Zhang L, et al
    The Role of the 17q21 Genotype in the Prevention of Early Childhood Asthma and Recurrent Wheeze by Vitamin D.
    Eur Respir J. 2019 Aug 22. pii: 13993003.00761-2019.
    PubMed     Abstract available


  246. KRISHNA MT, Subramanian A, Adderley NJ, Zemedikun D, et al
    Allergic Diseases and Long Term Risk of Autoimmune Disorders: longitudinal cohort study and cluster analysis.
    Eur Respir J. 2019 Aug 14. pii: 13993003.00476-2019.
    PubMed     Abstract available


  247. CHACHI L, Diver S, Kaul H, Rebelatto MC, et al
    Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma.
    Eur Respir J. 2019 Aug 7. pii: 13993003.00930-2019.
    PubMed    


  248. TOREN K, Olin AC, Johnsson A, Vikgren J, et al
    The association between cadmium exposure and chronic airflow limitation and emphysema: The Swedish CArdioPulmonary BioImage Study (SCAPIS Pilot).
    Eur Respir J. 2019 Aug 7. pii: 13993003.00960-2019.
    PubMed    


  249. JHA A, Dunning J, Tunstall T, Thwaites RS, et al
    Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza.
    Eur Respir J. 2019 Aug 7. pii: 13993003.00949-2019.
    PubMed     Abstract available


  250. KHREIS H, Cirach M, Mueller N, de Hoogh K, et al
    Outdoor Air Pollution and the Burden of Childhood Asthma across Europe.
    Eur Respir J. 2019 Aug 7. pii: 13993003.02194-2018.
    PubMed     Abstract available


  251. PEJLER G
    The emerging role of mast cell proteases in asthma.
    Eur Respir J. 2019 Aug 1. pii: 13993003.00685-2019.
    PubMed     Abstract available


  252. SUOJALEHTO H, Suuronen K, Cullinan P
    Specific challenge testing for occupational asthma: revised handbook.
    Eur Respir J. 2019;54.
    PubMed    


  253. GAGA M, Khaltaev N, Varghese C
    Inhaled corticosteroids in asthma and the need for universal health coverage.
    Eur Respir J. 2019;54.
    PubMed    


  254. LAUBHAHN K, Schaub B
    Paediatric severe asthma: a need for novel innate molecular phenotypes.
    Eur Respir J. 2019;54.
    PubMed    


  255. BOEHM A, Pizzini A, Sonnweber T, Loeffler-Ragg J, et al
    Using Google Trends to investigate global COPD awareness.
    Eur Respir J. 2019;54.
    PubMed    


  256. ZHAO CN, Wu Q, Pan HF
    Using Google Trends to investigate global COPD awareness.
    Eur Respir J. 2019;54.
    PubMed    


    July 2019
  257. SINTOBIN I, Siroux V, Holtappels G, Pison C, et al
    Sensitisation to staphylococcal enterotoxins and asthma severity: a longitudinal study in the EGEA cohort.
    Eur Respir J. 2019 Jul 8. pii: 13993003.00198-2019.
    PubMed     Abstract available


  258. AZIM A, Barber C, Dennison P, Riley J, et al
    Exhaled volatile organic compounds in adult asthma: a systematic review.
    Eur Respir J. 2019 Jul 4. pii: 13993003.00056-2019.
    PubMed     Abstract available


  259. BOULET LP, Reddel H, Bateman E, Pedersen S, et al
    The Global Initiative for Asthma (GINA): 25 years later.
    Eur Respir J. 2019 Jul 4. pii: 13993003.00598-2019.
    PubMed     Abstract available


  260. LASKA IF, Chalmers JD
    Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?
    Eur Respir J. 2019;54.
    PubMed    



  261. "Do bacteria have a role in asthma development?" J. Armann and E. von Mutius. Eur Respir J 2010; 36: 469-471.
    Eur Respir J. 2019;54.
    PubMed    


  262. MILANZI EB, Gehring U
    Detrimental effects of air pollution on adult lung function.
    Eur Respir J. 2019;54.
    PubMed    


  263. LU W, Sharma P, Eapen MS, Sohal SS, et al
    Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis.
    Eur Respir J. 2019;54.
    PubMed    


    June 2019
  264. PERSSON C
    In vivo observations provide insight into roles of eosinophils and epithelial cells in asthma.
    Eur Respir J. 2019 Jun 27. pii: 13993003.00470-2019.
    PubMed     Abstract available


  265. WILKINSON M, Maidstone R, Loudon A, Blaikley J, et al
    Circadian rhythm of exhaled biomarkers in health and asthma.
    Eur Respir J. 2019 Jun 20. pii: 13993003.01068-2019.
    PubMed     Abstract available


  266. JANSON C, Malinovschi A, Amaral AFS, Accordini S, et al
    Bronchodilator reversibility in asthma and COPD: Findings from three large population studies.
    Eur Respir J. 2019 Jun 20. pii: 13993003.00561-2019.
    PubMed     Abstract available


  267. FLEMING M, Fitton CA, Steiner MFC, McLay JS, et al
    Educational and health outcomes of children treated for asthma: Scotland-wide record linkage study of 683,716 children.
    Eur Respir J. 2019 Jun 13. pii: 13993003.02309-2018.
    PubMed     Abstract available


  268. NAGAKUMAR P, Puttur F, Gregory LG, Denney L, et al
    Pulmonary type2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids.
    Eur Respir J. 2019 Jun 4. pii: 13993003.01809-2018.
    PubMed     Abstract available


  269. OSCULLO YEPEZ G, Sierra-Parraga JM, Posadas Blazquez T, Martinez-Garcia MA, et al
    Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination?
    Eur Respir J. 2019;53.
    PubMed    


  270. REDDEL HK, FitzGerald JM, Bateman ED, Bacharier LB, et al
    GINA 2019: a fundamental change in asthma management: Treatment of asthma with short-acting bronchodilators alone is no longer recommended for adults and adolescents.
    Eur Respir J. 2019;53.
    PubMed    


  271. SORIANO JB
    The evolution of COPD species; or, something is changing for good in COPD.
    Eur Respir J. 2019;53.
    PubMed    


  272. SEIJO LM, Soriano JB, Peces-Barba G
    New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD.
    Eur Respir J. 2019;53.
    PubMed    


    May 2019
  273. SHOEMARK A, Cant E, Carreto L, Smith A, et al
    A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Eur Respir J. 2019 May 31. pii: 13993003.00303-2019.
    PubMed     Abstract available


  274. RAVI A, Chowdhury S, Dijkhuis A, Bonta PI, et al
    Neutrophilic inflammation in asthma and defective epithelial translational control.
    Eur Respir J. 2019 May 20. pii: 13993003.00547-2019.
    PubMed     Abstract available


  275. VOGELBERG C, Szefler SJ, Vrijlandt EJLE, Boner AL, et al
    Tiotropium add-on therapy is safe and reduces seasonal worsenings in paediatric asthma patients.
    Eur Respir J. 2019 May 16. pii: 13993003.01824-2018.
    PubMed     Abstract available


  276. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma.
    Eur Respir J. 2019 May 2. pii: 13993003.01580-2018.
    PubMed    


  277. CHOI H, Yang B, Nam H, Kyoung DS, et al
    Population-based prevalence of bronchiectasis and associated comorbidities in South Korea.
    Eur Respir J. 2019 May 2. pii: 13993003.00194-2019.
    PubMed    


  278. HOLLEY S, Knibb R, Latter S, Liossi C, et al
    Development and validation of the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ).
    Eur Respir J. 2019 May 2. pii: 13993003.01375-2018.
    PubMed     Abstract available


  279. O'BYRNE P, Fabbri LM, Pavord ID, Papi A, et al
    Asthma progression and mortality: The role of inhaled corticosteroids.
    Eur Respir J. 2019 May 2. pii: 13993003.00491-2019.
    PubMed     Abstract available


  280. MCBRIEN CN, Menzies-Gow A
    Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials.
    Eur Respir J. 2019;53.
    PubMed    


  281. SCHLEICH F, Louis R
    It needs more than just eosinophils to cause emphysema in COPD.
    Eur Respir J. 2019;53.
    PubMed    


  282. WALSH JA, Maddocks M, Man WD
    Supplemental oxygen during exercise training in COPD: full of hot air?
    Eur Respir J. 2019;53.
    PubMed    


  283. SCHUETZ P, Stolz D
    Guiding antibiotic treatment with inflammatory biomarkers in COPD? Another brick in the wall.
    Eur Respir J. 2019;53.
    PubMed    


    April 2019
  284. PILLARISETTI N, Broderick D, Ainsworth A, Mulholland A, et al
    The airway microbiota in children newly diagnosed with bronchiectasis largely retains its diversity.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00704-2019.
    PubMed    


  285. PEROTIN JM, Schofield JPR, Wilson SJ, Ward J, et al
    Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00453-2019.
    PubMed    


  286. HENKLE E, Curtis JR, Chen L, Chan B, et al
    Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.
    Eur Respir J. 2019 Apr 18. pii: 13993003.01896-2018.
    PubMed     Abstract available


  287. TABEZE L, Marchand-Adam S, Borie R, Justet A, et al
    Severe asthma with blood hypereosinophilia associated with JAK2V617F mutation: a case series.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02248-2018.
    PubMed    


  288. EFTHIMIOU J, Poll C, Barnes PJ
    Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02390-2018.
    PubMed     Abstract available


  289. LEHTO K, Pedersen NL, Almqvist C, Lu Y, et al
    Asthma and affective traits in adults: a genetically informative study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02142-2018.
    PubMed     Abstract available


  290. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    PubMed     Abstract available


  291. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.01257-2018.
    PubMed     Abstract available


  292. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    PubMed    


  293. NANNINI LJ
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    PubMed    


  294. MARTIN MJ, Harrison TW
    Is it time to move away from short-acting beta-agonists in asthma management?
    Eur Respir J. 2019;53.
    PubMed    


  295. BOUSQUET J
    Electronic clinical decision support system (eCDSS) in the management of asthma: from theory to practice.
    Eur Respir J. 2019;53.
    PubMed    


  296. HOBBS BD, Tantisira KG
    MicroRNAs in COPD: small molecules with big potential.
    Eur Respir J. 2019;53.
    PubMed    


  297. ASHDOWN H, Steiner M
    Delivering high value therapies in COPD: the secret is in the marketing.
    Eur Respir J. 2019;53.
    PubMed    


  298. WOUTERS EFM
    The Medusa faces of dyspnoea in COPD.
    Eur Respir J. 2019;53.
    PubMed    


  299. SUISSA S, Ariel A
    Triple therapy in COPD: only for the right patient.
    Eur Respir J. 2019;53.
    PubMed    


  300. PAPI A, Petruzzelli S, Vezzoli S, Georges G, et al
    Triple therapy for all patients with severe symptomatic COPD at risk of exacerbations.
    Eur Respir J. 2019;53.
    PubMed    


    March 2019
  301. JIANG Y, Gruzieva O, Wang T, Forno E, et al
    Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescents.
    Eur Respir J. 2019 Mar 28. pii: 13993003.00102-2019.
    PubMed     Abstract available


  302. WANG J, Pindus M, Janson C, Sigsgaard T, et al
    Dampness, mould, onset and remission of adult respiratory symptoms, asthma and rhinitis.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01921-2018.
    PubMed     Abstract available


  303. KUO CR, Lipworth B
    Differences in asthma control and lung function in relation to allergic status.
    Eur Respir J. 2019 Mar 17. pii: 13993003.02102-2018.
    PubMed    


  304. PAPAKONSTANTINOU E, Savic S, Siebeneichler A, Strobel W, et al
    A pilot study to test the feasibility of histological characterisation of asthma-COPD overlap.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01941-2018.
    PubMed    


  305. SHAHEEN SO, Lundholm C, Brew BK, Almqvist C, et al
    Prescribed analgesics in pregnancy and risk of childhood asthma.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01090-2018.
    PubMed     Abstract available


  306. MOKOKA MC, McDonnell MJ, MacHale E, Cushen B, et al
    Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy. Results from a systematic literature review and modelling study.
    Eur Respir J. 2019 Mar 7. pii: 13993003.02161-2018.
    PubMed     Abstract available


    February 2019
  307. BLOOM CI, Saglani S, Feary J, Jarvis D, et al
    Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population based cohort 2006-2016.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02130-2018.
    PubMed     Abstract available


  308. DEN DEKKER HT, Burrows K, Felix JF, Salas LA, et al
    Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course.
    Eur Respir J. 2019 Feb 14. pii: 13993003.01795-2018.
    PubMed     Abstract available


  309. GUPTA S, Price C, Agarwal G, Chan D, et al
    The Electronic Asthma Management System (eAMS) Improves Primary Care Asthma Management.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02241-2018.
    PubMed     Abstract available


  310. DOYLE AD, Mukherjee M, LeSuer WE, Bittner TB, et al
    Eosinophil-derived IL-13 Promotes Emphysema.
    Eur Respir J. 2019 Feb 6. pii: 13993003.01291-2018.
    PubMed     Abstract available


  311. NAIR P, O'Byrne PM
    The interleukin-13 paradox in asthma: effective biology, ineffective biologicals.
    Eur Respir J. 2019;53.
    PubMed    


  312. SHTEINBERG M, Shah A, Elborn JS
    New insights into immunological responses to infection in bronchiectasis.
    Eur Respir J. 2019;53.
    PubMed    


  313. PAHUS L, Jaffuel D, Vachier I, Bourdin A, et al
    Randomised controlled trials in severe asthma: selection by phenotype or stereotype.
    Eur Respir J. 2019;53.
    PubMed    


  314. GUAN WJ, Han XR, de la Rosa-Carrillo D, Martinez-Garcia MA, et al
    The significant global economic burden of bronchiectasis: a pending matter.
    Eur Respir J. 2019;53.
    PubMed    


    January 2019
  315. VAN DER MEER AN, de Jong K, Hoekstra-Kuik A, Bel EH, et al
    Dynamic hyperinflation impairs daily life activity in asthma.
    Eur Respir J. 2019 Jan 24. pii: 13993003.01500-2018.
    PubMed     Abstract available


  316. CHEN R, Zhang Q, Chen S, Tang H, et al
    IL-17F, rather than IL-17A, underlies airway inflammation in a steroid insensitive toluene diisocyanate-induced asthma model.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01510-2018.
    PubMed     Abstract available


  317. COTTIN V, Azuma A, Raghu G, Stansen W, et al
    Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01655-2018.
    PubMed    


  318. CRAMER N, Sedlacek L, Tummler B, Welte T, et al
    Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02191-2018.
    PubMed    


  319. PIETERS A, Bakker M, Hoek RAS, Altenburg J, et al
    The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral center.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02081-2018.
    PubMed    


  320. ROTH M, Stolz D
    Biomarkers and personalised medicine for asthma.
    Eur Respir J. 2019;53.
    PubMed    


  321. METERSKY ML, ZuWallack RL
    Pulmonary rehabilitation for bronchiectasis: if not now, when?
    Eur Respir J. 2019;53.
    PubMed    


    December 2018
  322. TONGA KO, Berend N, Thamrin C, Farah CS, et al
    Lung elastic recoil and ventilation heterogeneity of diffusion-dependent airways in older people with asthma and fixed airflow obstruction.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01028-2018.
    PubMed    


  323. PAVLIDIS S, Takahashi K, Kwong FNK, Xie J, et al
    "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00938-2018.
    PubMed     Abstract available


  324. PATEL S, Cole AD, Nolan CM, Barker RE, et al
    Pulmonary rehabilitation in bronchiectasis: a propensity matched study.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01264-2018.
    PubMed     Abstract available


  325. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    PubMed     Abstract available


  326. DIEL R, Chalmers JD, Rabe KF, Nienhaus A, et al
    Economic burden of bronchiectasis in Germany.
    Eur Respir J. 2018 Dec 5. pii: 13993003.02033-2018.
    PubMed     Abstract available


    November 2018
  327. HANSEN AV, Ali Z, Malchau SS, Blafoss J, et al
    Fertility treatment among women with asthma - A case-control study of 3689 women with live births.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00597-2018.
    PubMed     Abstract available


  328. TUOMISTO LE, Ilmarinen P, Lehtimaki L, Tommola M, et al
    Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00904-2018.
    PubMed     Abstract available


  329. SHRIMANKER R, Pavord ID, Yancey S, Heaney LG, et al
    Exacerbations of severe asthma in patients treated with Mepolizumab.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01127-2018.
    PubMed    


  330. WELLS JM, Colangelo LA, Sivarajan L, Thyagarajan B, et al
    Inflammation and Endothelial Activation in Early Adulthood are Associated with Future Emphysema: The CARDIA Lung Study.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01532-2018.
    PubMed    


  331. BUSSE WW, Brusselle GG, Korn S, Kuna P, et al
    Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.
    Eur Respir J. 2018 Nov 15. pii: 13993003.00948-2018.
    PubMed     Abstract available


  332. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2018;52.
    PubMed    


  333. SKOPELJA-GARDNER S, Theprungsirikul J, Meagher RE, Beliveau CM, et al
    Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response.
    Eur Respir J. 2018 Nov 1. pii: 13993003.01891-2018.
    PubMed    


  334. ALIBERTI S, Polverino E, Chalmers JD, Altenburg J, et al
    The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.
    Eur Respir J. 2018;52.
    PubMed    


  335. DJUKANOVIC R, Adcock IM, Anderson G, Bel EH, et al
    The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.
    Eur Respir J. 2018;52.
    PubMed    


    October 2018
  336. BROWN T, Jones T, Gove K, Barber C, et al
    Randomised Controlled Trials in Severe Asthma: Selection by Phenotype or Stereotype.
    Eur Respir J. 2018 Oct 25. pii: 13993003.01444-2018.
    PubMed     Abstract available


  337. RUSCONI F, Fernandes RM, Pijnenburg MWH, Grigg J, et al
    The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers.
    Eur Respir J. 2018;52.
    PubMed    


    September 2018
  338. CONTRERAS ZA, Chen Z, Roumeliotaki T, Annesi-Maesano I, et al
    Does early-onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts.
    Eur Respir J. 2018 Sep 12. pii: 13993003.00504-2018.
    PubMed     Abstract available


  339. VOLMER T, Effenberger T, Trautner C, Buh R, et al
    Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature.
    Eur Respir J. 2018 Sep 6. pii: 13993003.00703-2018.
    PubMed     Abstract available


  340. BOAVENTURA R, Sibila O, Agusti A, Chalmers JD, et al
    Treatable traits in bronchiectasis.
    Eur Respir J. 2018;52.
    PubMed    


  341. ARDURA-GARCIA C, Pedersen ESL, Goutaki M
    The limitations of cross-sectional data: perinatal risk factors for asthma.
    Eur Respir J. 2018;52.
    PubMed    


  342. ADLER D
    Bridging the gap in knowledge between dyspnoea scientists and clinicians.
    Eur Respir J. 2018;52.
    PubMed    


    August 2018
  343. BLEECKER ER, Wechsler ME, Mark FitzGerald J, Menzies-Gow A, et al
    Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe Asthma.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00936-2018.
    PubMed     Abstract available


  344. MILANZI EB, Koppelman GH, Smit HA, Wijga AH, et al
    Air pollution exposure and lung function until age 16: the PIAMA birth cohort study.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00218-2018.
    PubMed     Abstract available


  345. GOSENS R, Gross N
    The mode of action of anticholinergics in asthma.
    Eur Respir J. 2018 Aug 16. pii: 13993003.01247-2017.
    PubMed     Abstract available


  346. BEDARD A, Northstone K, Holloway JW, Henderson AJ, et al
    Maternal dietary antioxidant intake in pregnancy and childhood respiratory and atopic outcomes: birth cohort study.
    Eur Respir J. 2018 Aug 9. pii: 13993003.00507-2018.
    PubMed     Abstract available


  347. WESTBERG AP, Salonen MK, von Bondsdorff M, Osmond C, et al
    Maternal adiposity in pregnancy and offspring asthma in adulthood.
    Eur Respir J. 2018 Aug 2. pii: 13993003.01152-2018.
    PubMed    


  348. MARTIN JG
    Airway smooth muscle may drive mucus hypersecretion in asthma.
    Eur Respir J. 2018;52.
    PubMed    


  349. CULVER BH
    Assessment of severity and prognosis in COPD: moving beyond percent of predicted.
    Eur Respir J. 2018;52.
    PubMed    


    July 2018
  350. AGARWAL R, Dhooria S, Singh Sehgal I, Aggarwal AN, et al
    A randomized trial of voriconazole and prednisolone monotherapy in acute-stage ABPA complicating asthma.
    Eur Respir J. 2018 Jul 26. pii: 13993003.01159-2018.
    PubMed    


  351. POLVERINO E, Dimakou K, Hurst J, Angel Martinez-Garcia M, et al
    The overlap between bronchiectasis and chronic airways diseases: state of the art and future directions.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00328-2018.
    PubMed     Abstract available


  352. LEX C, Reuter M, Schuster A, Grabenhenrich L, et al
    Lung function trajectories using different reference equations in a birth cohort study up to the age of 20 years.
    Eur Respir J. 2018 Jul 12. pii: 13993003.00364-2018.
    PubMed    


  353. MES MA, Katzer CB, Chan AHY, Wileman V, et al
    Pharmacists and medication adherence in asthma: a systematic review and meta-analysis.
    Eur Respir J. 2018 Jul 5. pii: 13993003.00485-2018.
    PubMed     Abstract available


  354. ALLEN DJ, Holmes LJ, Hince KA, Daly R, et al
    Non-adherence with inhaled preventer therapy in severe asthmatic patients on long term Omalizumab.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01025-2018.
    PubMed    


  355. ZHANG M, Litonjua AA, Mueller NT
    Maternal antibiotic use and child asthma: is the association causal?
    Eur Respir J. 2018;52.
    PubMed    


  356. ANDRIANASOLO RM, Kesse-Guyot E, Adjibade M, Hercberg S, et al
    Associations between dietary scores with asthma symptoms and asthma control in adults.
    Eur Respir J. 2018;52.
    PubMed     Abstract available



  357. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecke
    Eur Respir J. 2018;52.
    PubMed    


  358. YOHANNES AM
    Serotonergic antidepressants in COPD: beneficial or harmful?
    Eur Respir J. 2018;52.
    PubMed    


  359. ERNST P
    Blood eosinophils in COPD and the future risk of pneumonia.
    Eur Respir J. 2018;52.
    PubMed    


    June 2018
  360. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR).
    Eur Respir J. 2018 Jun 25. pii: 13993003.01927-2017.
    PubMed     Abstract available


  361. FAIZ A, Weckmann M, Tasena H, Vermeulen CJ, et al
    Profiling of healthy and asthmatic airway smooth muscle cells following IL-1beta treatment: a novel role for CCL20 in chronic mucus hyper-secretion.
    Eur Respir J. 2018 Jun 25. pii: 13993003.00310-2018.
    PubMed     Abstract available


  362. GOEMINNE CP, Cox B, Finch S, Loebinger MR, et al
    The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation. A case-crossover analysis.
    Eur Respir J. 2018 Jun 14. pii: 13993003.02557-2017.
    PubMed     Abstract available


  363. MAC AOGAIN M, Chandrasekaran R, Lim Yick Hou A, Teck Boon L, et al
    IMMUNOLOGICAL COROLLARY OF THE PULMONARY MYCOBIOME IN BRONCHIECTASIS: THE CAMEB STUDY.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00766-2018.
    PubMed     Abstract available


  364. RONIT A, Kristensen T, Hoseth VS, Abou-Kassem D, et al
    Computed tomography quantification of emphysema in people living with HIV and uninfected controls.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00296-2018.
    PubMed     Abstract available


  365. GOMEZ REAL F, Burgess JA, Villani S, Dratva J, et al
    Maternal age at delivery, lung function and asthma in offspring: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  366. SUGIYAMA T
    A multi-organ loss of tissue phenotype in COPD: involvement of the functional muscle-bone unit.
    Eur Respir J. 2018;51.
    PubMed    


  367. RICCI F, Wollmer P, Engstrom G, Fedorowski A, et al
    Dysregulation of the "inflammatory reflex" with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD.
    Eur Respir J. 2018;51.
    PubMed    


  368. ANDREAS S
    The association of cardiovascular autonomic dysfunction and the prediction of COPD can be explained by neurohumoral activation.
    Eur Respir J. 2018;51.
    PubMed    


    May 2018
  369. DUFETELLE E, Bokov P, Delclaux C, Beydon N, et al
    Should reversibility be assessed in all asthmatic children with normal spirometry?
    Eur Respir J. 2018 May 31. pii: 13993003.00373-2018.
    PubMed    


  370. HYLAND ME, Jones RC, Lanario JW, Masoli M, et al
    The construction and validation of the Severe Asthma Questionnaire (SAQ).
    Eur Respir J. 2018 May 24. pii: 13993003.00618-2018.
    PubMed     Abstract available


  371. SANDRI BJ, Kaplan A, Hodgson SW, Peterson M, et al
    Multi-Omic Molecular Profiling of Lung Cancer in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2018 May 24. pii: 13993003.02665-2017.
    PubMed     Abstract available


  372. BIDAD N, Barnes N, Griffiths C, Horne R, et al
    UNDERSTANDING PATIENTS' PERCEPTIONS OF ASTHMA CONTROL: A QUALITATIVE STUDY.
    Eur Respir J. 2018 May 17. pii: 13993003.01346-2017.
    PubMed     Abstract available


  373. BURGE PS, Moore VC, Robertson AS, Walters GI, et al
    Do laboratory challenge tests for occupational asthma represent what happens in the workplace?
    Eur Respir J. 2018 May 10. pii: 13993003.00059-2018.
    PubMed     Abstract available


  374. BOURBEAU J, Farias R
    Making sense of telemedicine in the management of COPD.
    Eur Respir J. 2018;51.
    PubMed    


  375. EKSTROM M, Elmberg V, Lindow T, Wollmer P, et al
    Breathlessness measurement should be standardised for the level of exertion.
    Eur Respir J. 2018;51.
    PubMed    


  376. BUSSE WW
    Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
    Eur Respir J. 2018;51.
    PubMed    


  377. SCHEERENS C, Beernaert K, Pype P, Cohen J, et al
    Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed    


    April 2018
  378. LOEWEN K, Monchka B, Mahmud SM, Jong G', et al
    Prenatal antibiotic exposure and childhood asthma: a population-based study.
    Eur Respir J. 2018 Apr 20. pii: 13993003.02070-2017.
    PubMed     Abstract available


  379. TSAI YH, Parker JS, Yang IV, Kelada SNP, et al
    Meta-Analysis of Airway Epithelia Gene Expression in Asthma.
    Eur Respir J. 2018 Apr 12. pii: 13993003.01962-2017.
    PubMed     Abstract available


  380. TAKAHASHI K, Pavlidis S, Ng Kee Kwong F, Hoda U, et al
    Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis.
    Eur Respir J. 2018 Apr 12. pii: 13993003.02173-2017.
    PubMed     Abstract available


  381. HAVET A, Zerimech F, Sanchez M, Siroux V, et al
    Outdoor air pollution, exhaled 8-isoprostane and current asthma in adults: the EGEA study.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  382. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Ekstrom M, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed    


  383. RAMOS HERNANDEZ C, Nunez Fernandez M, Mouronte-Roibas C, Mosteiro Anon M, et al
    HypAir FeNO: an electrochemical sensor.
    Eur Respir J. 2018;51.
    PubMed    


    March 2018
  384. HANCOX RJ, Pavord ID, Sears MR
    Associations between blood eosinophils and decline in lung function among adults with and without asthma.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02536-2017.
    PubMed     Abstract available


  385. HUMBERT M, Taille C, Mala L, Le Gros V, et al
    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02523-2017.
    PubMed     Abstract available


  386. SHTEINBERG M, Stein N, Adir Y, Ken-Dror S, et al
    Prevalence, risk factors and prognosis of Non tuberculous mycobacteria infection among people with bronchiectasis: a population survey.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02469-2017.
    PubMed    


  387. CHANOINE S, Sanchez M, Pin I, Temam S, et al
    Multimorbidity-medications and poor asthma prognosis.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02114-2017.
    PubMed     Abstract available


  388. TO T, Feldman LY, Zhu J, Gershon AS, et al
    Asthma Health Services Utilization Before, During, and After Pregnancy: A Population-Based Cohort Study.
    Eur Respir J. 2018 Mar 8. pii: 13993003.00209-2018.
    PubMed     Abstract available


  389. LEE J, Ren Tay T, Radhakrishna N, Hore-Lacy F, et al
    Non-adherence in the era of severe asthma biologics and thermoplasty.
    Eur Respir J. 2018 Mar 8. pii: 13993003.01836-2017.
    PubMed     Abstract available


  390. DIJK FN, Xu C, Melen E, Carsin AE, et al
    Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  391. HESTER KLM, Newton J, Rapley T, Ryan V, et al
    Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era.
    Eur Respir J. 2018 Mar 1. pii: 13993003.02402-2017.
    PubMed    


  392. PATTINSON KTS, Rowland MJ, Nickol AH, Quinlan J, et al
    Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain.
    Eur Respir J. 2018;51.
    PubMed    


    February 2018
  393. PERRY MM, Lavender P, Scott Kuo CH, Galea F, et al
    DNA methylation modules in airway smooth muscle are associated with asthma severity.
    Eur Respir J. 2018 Feb 15. pii: 13993003.01068-2017.
    PubMed    


  394. TURNER S, Fielding S, Devereux G
    First trimester fetal size and prescribed asthma medication at 15 years of age.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  395. NAGAKUMAR P, Gambir N, Sanghani N, Hall P, et al
    Role of a prolonged inpatient admission when evaluating children with problematic severe asthma.
    Eur Respir J. 2018;51.
    PubMed    



  396. "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel a
    Eur Respir J. 2018;51.
    PubMed    


  397. MARTINEZ-GARCIA MA
    Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers.
    Eur Respir J. 2018;51.
    PubMed    


  398. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  399. LAVIGNE E, Belair MA, Rodriguez Duque D, Do MT, et al
    Effect modification of perinatal exposure to air pollution and childhood asthma incidence.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01884-2017.
    PubMed     Abstract available


  400. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    PubMed    


  401. GRZESKOWIAK LE, Smithers LG, Grieger JA, Bianco-Miotto T, et al
    Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study.
    Eur Respir J. 2018;51.
    PubMed    


  402. COUMOU H, Westerhof GA, de Nijs SB, Zwinderman AH, et al
    Predictors of accelerated decline in lung function in adult-onset asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  403. CELLI BR, Locantore N, Tal-Singer R, Riley J, et al
    Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  404. PEKKANEN J, Valkonen M, Taubel M, Tischer C, et al
    Indoor bacteria and asthma in adults: a multicentre case-control study within ECRHS II.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  405. HACCURIA A, Van Muylem A, Malinovschi A, Doan V, et al
    Small airways dysfunction: the link between allergic rhinitis and allergic asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  406. SIMILOWSKI T
    Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases.
    Eur Respir J. 2018;51.
    PubMed    


  407. CRINER GJ
    Revising our approach to conducting therapeutic clinical research in COPD.
    Eur Respir J. 2018;51.
    PubMed    


  408. HALPIN DMG
    Palliative care for people with COPD: effective but underused.
    Eur Respir J. 2018;51.
    PubMed    


  409. SORIANO JB, Burgel PR
    On Don Quixote and pink puffers: multi-organ loss of tissue COPD.
    Eur Respir J. 2018;51.
    PubMed    


  410. JONES R
    The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions?
    Eur Respir J. 2018;51.
    PubMed    


  411. SOHAL SS
    Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules.
    Eur Respir J. 2018;51.
    PubMed    


    January 2018
  412. MANISCALCO M, Paris D, Melck DJ, Molino A, et al
    Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study.
    Eur Respir J. 2018 Jan 18. pii: 13993003.01825-2017.
    PubMed    


  413. CHALMERS JD, Polverino E
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed    


  414. GUAN WJ, Huang Y, Chen CL, Chen RC, et al
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed    


  415. JORUP C, Lythgoe D, Bisgaard H
    Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  416. SULAIMAN I, Greene G, MacHale E, Seheult J, et al
    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  417. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    PubMed    


  418. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    PubMed    


  419. WONG C, Sullivan C, Jayaram L
    ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence.
    Eur Respir J. 2018;51.
    PubMed    


  420. CHALMERS JD, Ringshausen FC, Harris B, Elborn JS, et al
    Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
    Eur Respir J. 2018;51.
    PubMed    


  421. MUNOZ G, de Gracia J, Buxo M, Alvarez A, et al
    Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  422. CHOTIRMALL SH, Chalmers JD
    RESPIRE: breathing new life into bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed    


  423. AKSAMIT T, De Soyza A, Bandel TJ, Criollo M, et al
    RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  424. DE SOYZA A, Aksamit T, Bandel TJ, Criollo M, et al
    RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  425. MACNAUGHTON J, Oxley R, Rose A, Russell A, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed    


  426. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Lansing R, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed    


  427. AMBROSINO N
    Inspiratory muscle training in stable COPD patients: enough is enough?
    Eur Respir J. 2018;51.
    PubMed    


  428. SPRUIT MA, Singh SJ, Rochester CL, Greening NJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    PubMed    


  429. FOWLER SJ
    Breath analysis for label-free characterisation of airways disease.
    Eur Respir J. 2018;51.
    PubMed    


  430. WILSON KC, Krishnan JA, Sliwinski P, Criner GJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    PubMed    


  431. VANFLETEREN LEGW, Ullman A, Fabbri LM
    Time for a longer and better life for patients with COPD.
    Eur Respir J. 2018;51.
    PubMed    


  432. BEASLEY R, Braithwaite I, Fingleton J, Weatherall M, et al
    The inhaled corticosteroid/long-acting beta-agonist maintenance and reliever therapy regimen: where to from here?
    Eur Respir J. 2018;51.
    PubMed    


  433. CLINI E, Castaniere I, Tonelli R
    Looking for a chronic care model in COPD patients.
    Eur Respir J. 2018;51.
    PubMed    


  434. SCHULTZ K, Jelusic D, Wittmann M, Kramer B, et al
    Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  435. BEAUMONT M, Mialon P, Le Ber C, Le Mevel P, et al
    Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  436. ALCAZAR-NAVARRETE B, Ruiz Rodriguez O, Conde Baena P, Romero Palacios PJ, et al
    Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  437. DE VRIES R, Dagelet YWF, Spoor P, Snoey E, et al
    Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  438. KESSLER R, Casan-Clara P, Koehler D, Tognella S, et al
    COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  439. ROSE L, Istanboulian L, Carriere L, Thomas A, et al
    Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD(+)): a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


  440. STEURER-STEY C, Dalla Lana K, Braun J, Ter Riet G, et al
    Effects of the "Living well with COPD" intervention in primary care: a comparative study.
    Eur Respir J. 2018;51.
    PubMed     Abstract available


    December 2017
  441. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed    


  442. BOUSQUET J, Brusselle G, Buhl R, Busse WW, et al
    Care pathways for the selection of a biologic in severe asthma.
    Eur Respir J. 2017;50.
    PubMed    


  443. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed    


  444. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  445. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    Standardised classification of the aetiology of bronchiectasis using an objective algorithm.
    Eur Respir J. 2017;50.
    PubMed    


  446. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed    


  447. ANDRIANJAFIMASY M, Zerimech F, Akiki Z, Huyvaert H, et al
    Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  448. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    PubMed    


  449. DESLEE G, Leroy S, Perotin JM, Mal H, et al
    Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.
    Eur Respir J. 2017;50.
    PubMed    


  450. JOCHMANN A, Artusio L, Jamalzadeh A, Nagakumar P, et al
    Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


    November 2017
  451. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    PubMed    


  452. SALEH AD, Kwok B, Brown JS, Hurst JR, et al
    Correlates and assessment of excess cardiovascular risk in bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  453. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  454. BOURDIN A, Molinari N, Vachier I, Pahus L, et al
    Mortality: a neglected outcome in OCS-treated severe asthma.
    Eur Respir J. 2017;50.
    PubMed    


    October 2017
  455. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  456. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  457. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    PubMed    


  458. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Abstract available



  459. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    PubMed    


  460. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed    


  461. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


    September 2017
  462. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed    


  463. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed    


  464. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  465. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed    


  466. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  467. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  468. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed    


  469. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Abstract available



  470. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed    


  471. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Abstract available


  472. CONRAD A, Janciauskiene S, Kohnlein T, Fuge J, et al
    Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation.
    Eur Respir J. 2017;50.
    PubMed    


    July 2017
  473. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed    


    June 2017
  474. SCHLAPBACH LJ, Straney L, Gelbart B, Alexander J, et al
    Burden of disease and change in practice in critically ill infants with bronchiolitis.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    May 2017
  475. COATES AL, Wanger J, Cockcroft DW, Culver BH, et al
    ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    April 2017
  476. O'DONNELL DE, Casaburi R, Frith P, Kirsten A, et al
    Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  477. FANER R, Sibila O, Agusti A, Bernasconi E, et al
    The microbiome in respiratory medicine: current challenges and future perspectives.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  478. KNEIDINGER N, Milger K, Janitza S, Ceelen F, et al
    Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    March 2017
  479. STOCKLEY JA, Ismail AM, Hughes SM, Edgar R, et al
    Maximal mid-expiratory flow detects early lung disease in alpha1-antitrypsin deficiency.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  480. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  481. PERSSON LJ, Aanerud M, Hardie JA, Miodini Nilsen R, et al
    Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  482. HUSEBO GR, Gronseth R, Lerner L, Gyuris J, et al
    Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  483. WEDZICHA JA ERS CO-CHAIR, Miravitlles M, Hurst JR, Calverley PM, et al
    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  484. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  485. CROOK S, Busching G, Schultz K, Lehbert N, et al
    A multicentre validation of the 1-min sit-to-stand test in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  486. WILLIAMS MT, John D, Frith P
    Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  487. VOGELMEIER CF, Criner GJ, Martinez FJ, Anzueto A, et al
    Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    February 2017
  488. LORX A, Czovek D, Gingl Z, Makan G, et al
    Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  489. MOLIMARD M, Raherison C, Lignot S, Balestra A, et al
    Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  490. LOWES D, Al-Shair K, Newton PJ, Morris J, et al
    Predictors of mortality in chronic pulmonary aspergillosis.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    January 2017
  491. KARIMI R, Tornling G, Forsslund H, Mikko M, et al
    Differences in regional air trapping in current smokers with normal spirometry.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  492. BENMERAD M, Slama R, Botturi K, Claustre J, et al
    Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  493. KUNZ LI, Ten Hacken NH, Lapperre TS, Timens W, et al
    Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


  494. GREULICH T, Nell C, Hohmann D, Grebe M, et al
    The prevalence of diagnosed alpha1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
    Eur Respir J. 2017;49.
    PubMed     Abstract available


    November 2016
  495. HASEGAWA K, Mansbach JM, Ajami NJ, Espinola JA, et al
    Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.
    Eur Respir J. 2016;48:1329-1339.
    PubMed     Abstract available


    April 2016
  496. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Abstract available


    March 2016
  497. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: